Details
Stereochemistry | MIXED |
Molecular Formula | C23H36O5 |
Molecular Weight | 392.5289 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 3 / 4 |
E/Z Centers | 2 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CCCCC(O)(C\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1C\C=C/CCCC(=O)OC)C=C
InChI
InChIKey=TWCQWABAGCMHLL-ROVQGQOSSA-N
InChI=1S/C23H36O5/c1-4-6-15-23(27,5-2)16-11-13-19-18(20(24)17-21(19)25)12-9-7-8-10-14-22(26)28-3/h5,7,9,11,13,18-19,21,25,27H,2,4,6,8,10,12,14-17H2,1,3H3/b9-7-,13-11+/t18-,19-,21-,23?/m1/s1
Viprostol (also known as CL115,347), a prostaglandin E2 congener that was studied as an antihypertensive agent. Viprostol has a potent and prolonged blood pressure lowering effect in many models of hypertension. In clinical studies, viprostol has been demonstrated to lower arterial blood pressure significantly in man following transdermal and/or intravenous administration. The antihypertensive action of viprostol has been suggested to be the result of peripheral vasodilatation. In addition, the drug participated in a clinical trial in normal subjects and in patients with Raynaud's phenomenon. It was found the optimal dosage was 1000 ug; the effect could last for 84 hours; higher dosage may be associated with a "steal" phenomenon.
Approval Year
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Code | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C78568
Created by
admin on Fri Dec 15 16:16:20 GMT 2023 , Edited by admin on Fri Dec 15 16:16:20 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
SUB00079MIG
Created by
admin on Fri Dec 15 16:16:20 GMT 2023 , Edited by admin on Fri Dec 15 16:16:20 GMT 2023
|
PRIMARY | |||
|
O2Y6I4Y8TF
Created by
admin on Fri Dec 15 16:16:20 GMT 2023 , Edited by admin on Fri Dec 15 16:16:20 GMT 2023
|
PRIMARY | |||
|
W-34
Created by
admin on Fri Dec 15 16:16:20 GMT 2023 , Edited by admin on Fri Dec 15 16:16:20 GMT 2023
|
PRIMARY | |||
|
DTXSID301021620
Created by
admin on Fri Dec 15 16:16:20 GMT 2023 , Edited by admin on Fri Dec 15 16:16:20 GMT 2023
|
PRIMARY | |||
|
100000079119
Created by
admin on Fri Dec 15 16:16:20 GMT 2023 , Edited by admin on Fri Dec 15 16:16:20 GMT 2023
|
PRIMARY | |||
|
6438370
Created by
admin on Fri Dec 15 16:16:20 GMT 2023 , Edited by admin on Fri Dec 15 16:16:20 GMT 2023
|
PRIMARY | |||
|
CHEMBL2107669
Created by
admin on Fri Dec 15 16:16:20 GMT 2023 , Edited by admin on Fri Dec 15 16:16:20 GMT 2023
|
PRIMARY | |||
|
C152893
Created by
admin on Fri Dec 15 16:16:20 GMT 2023 , Edited by admin on Fri Dec 15 16:16:20 GMT 2023
|
PRIMARY | |||
|
73647-73-1
Created by
admin on Fri Dec 15 16:16:20 GMT 2023 , Edited by admin on Fri Dec 15 16:16:20 GMT 2023
|
PRIMARY | |||
|
5722
Created by
admin on Fri Dec 15 16:16:20 GMT 2023 , Edited by admin on Fri Dec 15 16:16:20 GMT 2023
|
PRIMARY |
ACTIVE MOIETY